Zevra Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.92 +0.54 (+6.44%) USD | NASDAQ | Jan 13, 16:00

8.92 0.00 (0.00%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Verastem, Inc.	--
ADMA Biologics, Inc.	Upgrade
Akebia Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--